Liver News and Research

RSS

New project to combat DMD-related fibrosis receives major funding boost

Duchenne muscular dystrophy is one of the most common congenital diseases in the world, affecting one in 3,500 Canadian males. DMD is caused by mutations in the dystrophin gene that results in progressive muscle degeneration and there are currently no effective treatments for DMD.

17 Aug 2018

Increasing dietary protein may lower risk of diabetes in people with NAFLD

Increasing the amount of protein in the diet may reduce the liver's fat content and lower the risk of diabetes in people with nonalcoholic fatty liver disease.

17 Aug 2018

Brief exposures to stressors can be beneficial to cells, shows study

We've all heard the expression: "what doesn't kill you makes you stronger." Now, research led by a Salk Institute scientist suggests why, at a cellular level, this might be true.

17 Aug 2018

Researchers publish new paper on developing vaccine candidates for Helminthic parasites

Helminthic parasites, like hookworm and liver flukes (schistosomiasis), affect an estimated 1 billion people worldwide. Infection from hookworm and schistosomiasis result in a combined loss of as much as 92 million disability-adjusted life years annually.

17 Aug 2018

Eating white button mushrooms could improve regulation of glucose in the liver

Eating white button mushrooms can create subtle shifts in the microbial community in the gut, which could improve the regulation of glucose in the liver, according to a team of researchers.

16 Aug 2018

Researchers develop new method to diagnose broad range of cancers using malaria protein

In a spectacular new study, researchers from the University of Copenhagen have discovered a method of diagnosing a broad range of cancers at their early stages by utilizing a particular malaria protein, which sticks to cancer cells in blood samples. The researchers hope that this method can be used in cancer screenings in the near future.

16 Aug 2018

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

Vertex Pharmaceuticals Incorporated today announced the U.S. Food and Drug Administration approved KALYDECO® (ivacaftor) to include use in children with cystic fibrosis ages 12 to <24 months who have at least one mutation in their cystic fibrosis transmembrane conductance regulator gene that is responsive to KALYDECO based on clinical and/or in vitro assay data.

16 Aug 2018

Researchers win multi-million Euro award to conduct research into liver disease

A team of researchers from the School of Immunology and Microbial Sciences and the Dental Institute has secured a multi-million Euro award to conduct research into liver disease.

16 Aug 2018

Researchers focus on uncoupling obesity from diabetes

About 422 million people around the world, including more than 30 million Americans, have diabetes. Approximately ninety percent of them have type 2 diabetes. People with this condition cannot effectively use insulin, a hormone made by the pancreas that helps the body turn blood sugar into energy.

15 Aug 2018

Researchers discover new approach to alleviate chronic itch

Two receptors in the spinal cord and the right experimental drug: Researchers at the University of Zurich have discovered a new approach that suppresses itch.

14 Aug 2018

Study helps to better understand disease caused by Alpha-1 antitrypsin deficiency

The disease consists of a production deficit of Alpha-1 antitrypsin, which is produced in the liver. The main role of this protein is to protect the lungs from degradation or inflammation caused by infections that attach lung tissue, as well as from external agents such a tobacco or pollution.

14 Aug 2018

Simple intervention during routine care reduces alcohol consumption in men with HIV

Among the more than 1 million people in the U.S. living with HIV, 19 percent meet the criteria for an alcohol use disorder.

14 Aug 2018

Altered nitrogen metabolism may contribute to emergence of new cancer mutations

Nitrogen is a basic building block of all the body's proteins, RNA and DNA, so cancerous tumors are greedy for this element. Researchers at the Weizmann Institute of Science, in collaboration with colleagues from the National Cancer Institute and elsewhere, have now shown that in many cancers, the patient's nitrogen metabolism is altered, producing detectable changes in the body fluids and contributing to the emergence of new mutations in cancerous tissue.

13 Aug 2018

Lighter sedation fails to reduce risk of postoperative delirium in older patients

Johns Hopkins Medicine researchers say a study designed to see if reducing the amount of anesthesia reduces the risk of postoperative delirium in older patients surprisingly found that lighter sedation failed to do so in severely ill people undergoing hip fracture repair.

13 Aug 2018

Advances in treating hep C lead to new option for transplant patients

After her kidneys failed from the same illness that took the lives of her mother and brother, Anne Rupp went on dialysis in May 2016, spending three hours a day, three times a week undergoing the blood-cleaning procedure. She hated it.

13 Aug 2018

Quality-improvement project to standardize feeding practices helps micro preemies gain weight

A quality-improvement project to standardize feeding practices for micro preemies--preterm infants born months before their due date-- helped to boost their weight and nearly quadrupled the frequency of lactation consultations ordered in the neonatal intensive care unit, a multidisciplinary team from Children's National Health System finds.

13 Aug 2018

FDA approves first vaginal ring contraceptive that can be used for one year

The U.S. Food and Drug Administration today approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), which is a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire year.

10 Aug 2018

Liver News and Research

New project to combat DMD-related fibrosis receives major funding boost

Increasing dietary protein may lower risk of diabetes in people with NAFLD

Brief exposures to stressors can be beneficial to cells, shows study

Researchers publish new paper on developing vaccine candidates for Helminthic parasites

Eating white button mushrooms could improve regulation of glucose in the liver

Researchers develop new method to diagnose broad range of cancers using malaria protein

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

Researchers win multi-million Euro award to conduct research into liver disease

Researchers focus on uncoupling obesity from diabetes

Researchers discover new approach to alleviate chronic itch

Study helps to better understand disease caused by Alpha-1 antitrypsin deficiency

Simple intervention during routine care reduces alcohol consumption in men with HIV

Altered nitrogen metabolism may contribute to emergence of new cancer mutations

Lighter sedation fails to reduce risk of postoperative delirium in older patients

Advances in treating hep C lead to new option for transplant patients

Quality-improvement project to standardize feeding practices helps micro preemies gain weight

FDA approves first vaginal ring contraceptive that can be used for one year

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

Obesity in PTSD patients accounts for increased risk of type 2 diabetes mellitus

New laboratory-synthesized molecule appears to fight malaria effectively

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News